A favourable (molecular) signal for personalised medicine.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000235:genetics*; D000075202:Contraindications; D030661:Genetic Privacy; D006801:Humans; D008967:Molecular Biology / Q000639:trends*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D014481:United States; D014486:United States Food and Drug Administration; D018631:ras Proteins / Q000235:genetics*
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins